ODYSSEUS Trademark

Design, development and maintenance of software in the fields of genetic sequencing, genomes, genetic mapping, molecular genetics, gene regulation, molecular biology, synthetic biology, engineering biology, DNA assembly, DNA synthesis, genome editing, protein engineering, antibody engineering, microbiology, pharmaceuticals, medicine, diagnostic preparations, immunopharmaceuticals, vaccines, medicine, health, microorganisms, molecular sciences, bacteria, biochemicals, cells, stem cells, organoids, cancer stem cells, clinical trials, physiology, genetics, genomics, microbiome, metabolomics, metagenomics, proteomics, glycomics, biochemistry, therapeutics, targeted pharmaceutical therapies, bacteriology, gene expression, DNA sequencing, DNA screening, RNA sequencing, RNA screening, transgenes, biochemical reagents and biochemical assays; design, development and maintenance of software algorithms in the fields of biotechnology and modulating therapeutics; design, development and maintenance of software in the fields of oncology, regenerative medicine, immunotherapy, recombinant protein production, immunology, cell engineering, CAR-T, viral vector engineering, genetic engineering, biopharmaceuticals, molecular biology, modulating therapeutics, assay systems, antigens and in vitro assays; design, development and maintenance of machine learning software for use in bioinformatics, genetic sequencing, predicting protein expression, cell suppression and analysis of cell behaviours; research in the field of genetic diseases, namely research relating to gene regulation control services; research in the field of genetic engineering technology, namely, gene regulatory network analysis; scientific research services in the nature of analysis, management and review of technical data; development and testing of computing methods, algorithms and software; design, development and maintenance of machine learning software; research in the field of artificial intelligence software; design and development of lab information management systems; design and development of software testing methods; providing temporary use of non-downloadable software for controlling, monitoring, programming and adjusting environmental conditions for cell culture, cell therapy or gene therapy; software as a service (SaaS) services featuring software for collecting and interpreting clinical data; development and testing of computing methods, algorithms and software; platform as a service services (PAAS) services featuring computer platforms for use in drug development in the field of genomics and genetic medicines; computer aided diagnostic testing services in the field of pharmaceuticals; database development and maintenance services; design and development of computer platforms; research and development services in the fields of pharmacogenetics, targeted pharmaceutical therapies and drug delivery platforms; research and development services in the field of regenerative medicines for the treatment of fibrosis, age-associated disorders, senescence, rejuvenation, neurological disease, tissue injury and tissue repair; research and development services in the fields of pharmaceuticals, immunopharmaceuticals, neoplastic diseases, modulating therapeutics, enhancers, super-enhancers, promoters, synthetic super enhancers in gene expression, DNA sequences, RNA sequences, fluorescent reporters, genetic cassettes, transgenes, gene therapy, drug delivery agents, vectors, diagnostic biomarker reagents, cell cultures, cell engineering, immunology and vaccines; research and development services in the fields of synthetic biology, engineering biology, DNA assembly, DNA synthesis, genome editing, protein engineering and antibody engineering; research and development services for the treatment of cancers, carcinomas, leukaemias, central nervous system tumours, glioblastoma, colorectal liver metastasis, squamous cell carcinomas, pancreatic cancer, melanoma, breast cancer, sarcomas, paediatric solid tumours, hepatocellular carcinoma, cancer of the eye and metastatic tumours; research and development services for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, otologic, respiratory, neurological, gastrointestinal, pancreatic, nephrologic, musculoskeletal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; biological, biochemical, biomedical, bacteriological and pharmacological research, analysis, engineering and development services; biological research laboratory services; research in the field of cell engineering technology services, namely, cell suppression, cell activation, and cell programming and reprogramming; culturing of cells for others for scientific or medical research purposes; contract research services being scientific and medical research relating to enhancers, and super-enhancers and promoters; pharmaceutical drug development services; development of gene-based medicines; providing information about medical research in the fields of biopharmaceuticals, immunology, cell engineering and immunoassays; scientific services in the nature of scientific research relating to the isolation and cultivation of human tissues and cells; medical research laboratory services namely, research, analysis, characterising, development and production of therapeutics for the treatment of neoplastic diseases, carcinomas, leukaemias, central nervous system tumours, glioblastoma, colorectal liver metastasis, squamous cell carcinomas, pancreatic cancer, melanoma, breast cancer, sarcomas, paediatric solid tumours, hepatocellular carcinoma, cancer of the eye and metastatic tumours; genetic engineering services in the nature of drug development services in the field of gene silencing; research in the field of genetic sequencing and genotyping services; research in the nature of RNA sequencing services; scientific research, namely, analysis services regarding the safety and efficacy of new pharmaceuticals; diagnostic services in the field of immunology; polymerase engineering, chain reaction [PCR] testing for medical research purposes; engineering namely, preparation of reports in the field of biotechnology; testing of human tissues and stem cells for scientific or medical research purposes; biomedical research services relating to the use of biomarkers to investigate human immune response for medical purposes; design, research, analysis and engineering services relating to genetic cassettes; design and engineering services relating to genomic safe harbours, recombination sites, minimal promoters, insulators, splicing control elements, gene terminators, UTRs, capsids, fusion linkers, translational control elements and transcriptional units; research in the field of RNA sequence optimisation services; evaluation services relating to RNA quality for use with vaccines and therapeutics; drug development services, namely, translational control services in the field of gene expression; design of therapeutic payloads; consultancy, information and advisory services relating to all of the aforesaid services

Downloadable computer software programs for use in laboratory management systems and gene therapy platforms; downloadable software, namely, software for use with lab information management systems; downloadable computer software platforms for medical and scientific research; downloadable software for remote diagnostics; downloadable software using machine learning for analysing genomic data, designing gene therapy solutions and to assist with drug development; downloadable software using machine learning for use in genetic sequencing; algorithms, being computer software for use in designing genetic medicines and cancer immunotherapies; downloadable bioinformatics software; imaging apparatus and instruments for use in the study of proteins and peptides in drug development; downloadable data processing software; downloadable computer applications for use in the fields of oncology, recombinant protein production, immunology, cell engineering, viral vector engineering, genetic engineering, biopharmaceuticals, molecular biology, modulating therapeutics, assay systems, antigens and in vitro assays; downloadable software for predicting protein expression; downloadable software in the fields of genomes, genetic mapping, molecular genetics, gene regulation, molecular biology, microbiology, pharmaceuticals, medicine, diagnostic preparations, vaccines, medicine, health, microorganisms, molecular sciences, bacteria, biochemicals, cells, stem cells, clinical trials, physiology, genetics, genomics, microbiome, metabolomics, metagenomics, proteomics, glycomics, biochemistry, therapeutics, targeted pharmaceutical therapies, bacteriology, gene expression, DNA sequencing, DNA screening, biochemical reagents and biochemical assays; downloadable computer software for scientific analysis of genetic sequences; downloadable software for creating optimization algorithms in the fields of biotechnology and modulating therapeutics; software as a medical device (SAMD), for prevention, diagnosis, treatment, and monitoring of oncological diseases, genetic diseases, fibrosis and degenerative diseases; downloadable software using artificial intelligence for use in oncological, genetic and degenerative healthcare and in relation to fibrosis

Pharmaceutical, medical or veterinary preparations and substances for the treatment of oncological diseases, genetic diseases, fibrosis and degenerative diseases; pharmaceutical preparations for use in targeted pharmaceutical therapies for the treatment of oncological diseases, genetic diseases, fibrosis and degenerative diseases; pharmaceutical preparations and anti-neoplastic products for the treatment of neoplastic diseases; pharmaceutical preparations for the treatment of carcinomas and leukaemias; pharmaceutical preparations for the treatment of central nervous system tumours, glioblastoma, colorectal liver metastasis, squamous cell carcinomas, pancreatic cancer, melanoma, breast cancer hepatocellular carcinoma and metastatic tumours; enhancers or super-enhancers for medical or clinical use; engineered DNA as synthetic super enhancers in gene expression cassettes for medical or clinical use; DNA sequences for medical purposes; pharmaceutical preparations for use in regenerative medicines for treatment of fibrosis, age-associated disorders, senescence, rejuvenation, neurological disease, tissue injury and tissue repair; gene therapy pharmaceuticals for the treatment of neoplastic diseases, central nervous system tumours, glioblastoma, colorectal liver metastasis, squamous cell carcinomas, pancreatic cancer, melanoma, breast cancer hepatocellular carcinoma, leukaemias and metastatic tumours; pharmaceutical preparations being viral vectors namely, adenoviruses, adeno-associated viruses, poxviruses, reoviruses, lentiviruses and herpes simplex viruses; biotechnological preparations for medical use for the treatment of oncological diseases, genetic diseases, fibrosis and degenerative diseases; biological compounds in the nature of engineered DNA elements, viral vectors, enzymes and cytokines for use in the targeted pharmaceutical therapies; protein arrays for medical diagnosis purposes with diagnostic and therapeutic uses; chemical and enzyme preparations for medical or veterinary purposes for the treatment of oncological diseases, genetic diseases, fibrosis and degenerative diseases; reagents and diagnostic substances for use in testing for medical and veterinary purposes; drug delivery agents in the form of dissolvable films, tablets, capsules, powders, emulsions, injections, solutions and suspensions that facilitate the delivery of pharmaceutical preparations; clinical medical reagents; in vitro diagnostic and testing preparations for clinical, medical and medical laboratory use; pharmaceutical preparations in the field of modulating therapeutics; pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, otologic, respiratory, neurological, gastrointestinal, pancreatic, nephrologic, musculoskeletal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; biological preparations for the treatment of cancer; biological preparations for use in cell cultures for medical purposes; diagnostic biomarker reagents for medical purposes; cells for medical or clinical use; immune cells being cells for medical use; macromolecules being target antigens for medical use; vaccine preparations; therapeutic vaccines